Kardio Michal Cepelak s.r.o.

Clinical research at Kardio Michal Cepelak s.r.o. in Klatovy is centered on cardiovascular diseases, with studies looking at ways to lower the risk of serious heart and blood vessel events in people at elevated risk. These trials are designed to test new treatment approaches and improve prevention for conditions such as atherosclerotic cardiovascular disease and broader cardiovascular disease.

• Reducing the chance of heart attack, ischemic stroke, and coronary heart disease death in people at high cardiovascular risk
• Evaluating therapies for patients with atherosclerotic cardiovascular disease and related risk factors
• Assessing new options aimed at better long-term prevention of major cardiovascular events

The site is contributing to research that focuses on prevention, risk reduction, and treatment effectiveness for adults who have not yet had a prior heart attack or stroke but remain at significant cardiovascular risk.

Another key area of research at this hospital/clinic involves nutritional and metabolic diseases, especially hyperlipidemia and elevated LDL cholesterol. These studies explore whether newer therapies can improve cholesterol control and support better management of patients with high lipid levels or related cardiovascular risk.

• Testing treatments intended to lower LDL cholesterol more effectively
• Studying hyperlipidemia in adults with heart and vascular risk
• Exploring therapies that may help reduce future cardiovascular complications linked to abnormal lipids

This research reflects a strong interest in improving lipid management as part of broader prevention strategies for people at risk of first major cardiovascular events.

The site also supports research on treatment-related swelling, with studies focused on peripheral edema in patients using amlodipine. This work aims to better understand how swelling develops, how it can be measured, and whether switching therapies can improve comfort and tolerability.

• Comparing methods for assessing swelling in both legs
• Investigating peripheral edema in patients on long-term amlodipine treatment
• Looking at whether changing therapy can reduce symptoms and improve patient experience

This line of research combines symptom assessment with practical treatment evaluation, helping clarify how to manage a common side effect in everyday cardiovascular care.